PS315 is an allosteric PKC inhibitor with anticancer activity; it binds to the PIF pocket of aPKC and induces displacement of the active site residue Lys111; it inhibits both full-length and catalytic domain constructs of PKCζ (IC50 = 10 μM) and PKCη (IC50 = 30 μM).